Relationship between Cytochrome P450 2C19*2 Polymorphism and Stent Thrombosis following Percutaneous Coronary Intervention in Chinese Patients Receiving Clopidogrel

By Luo Y   Zhao Y-T   Verdo A   Qi W-G   Zhang D-F   Hu B  

The Journal of International Medical Research, Vol. 39, Iss. 5, 2011-09 ,pp. : 2012-2019

Field House Publishing

Access to resources Recommend Favorite

A polymorphism in the cytochrome P450 3A4 (CYP3A4) gene influences platelet activation and response to clopidogrel in patients with coronary artery disease

By  

Inpharma, Vol. 1, Iss. 1554, 2006-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Effect of dose on cyclosporine-induced suppression of hepatic cytochrome P450 3A2 and 2C11

By Brunner L.J.   Werner U.   Gravenall C.E.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 49, Iss. 2, 2000-03 ,pp. : 129-135

Elsevier

Access to resources Recommend Favorite

Cytochrome P₄₅₀ 2C9 phenotyping using low-dose tolbutamide

By Jetter Alexander   Kinzig-Schippers Martina   Skott Andreas   Lazar Andreas   Tomalik-Scharte Dorota   Kirchheiner Julia   Walchner-Bonjean Monika   Hering Ursula   Jakob Verena   Rodamer Michael   Jabrane Wafaâ   Kasel Dirk   Brockmöller Jürgen   Fuhr Uwe   Sörgel Fritz  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 3, 2004-05 ,pp. : 165-171

Springer Publishing Company

Access to resources Recommend Favorite

Prasugrel superior to clopidogrel in acute coronary syndrome?

By  

Inpharma, Vol. 1, Iss. 1605, 2007-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite